Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis

Clinical Immunology

Volumn 123, Issue 1, 2007, Pages 82-88

  Tamby, Mathieu C ^a   Servettaz, Amélie ^a   Guilpain, Philippe ^a   Tamas, Nicolas ^a   Berezné, Alice ^a   Batteux, Frédéric ^a   Reinbolt, Joseph ^b   Guillevin, Loïc ^a   Weill, Bernard ^a   Mouthon, Luc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

Author keywords

Antinuclear antibodies; Antitopoisomerase 1 antibodies; HEp 2 cells; Immunoblot; Systemic sclerosis

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; ANTITOPOISOMERASE 1 ANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE; ENZYME ANTIBODY; IMMUNOGLOBULIN G; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEP 2 CELL; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE; CENTROMERE; DNA TOPOISOMERASES, TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 33947205114     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.12.003     Document Type: Article

References (17)

1. Clements P.J. Systemic sclerosis (scleroderma) and related disorders: clinical aspects. Bailliere's Best Pract. Res. Clin. Rheumatol. 14 1 (2000) 1-16
2. Hesselstrand R., Scheja A., Shen G.Q., Wiik A., and Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42 4 (2003) 534-540
3. Moroi Y., Peebles C., Fritzler M.J., Steigerwald J., and Tan E.M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl. Acad. Sci. U. S. A. 77 3 (1980) 1627-1631
4. Weiner E.S., Earnshaw W.C., Senecal J.L., Bordwell B., Johnson P., and Rothfield N.F. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum. 31 3 (1988) 378-385
5. Bunn C.C., Denton C.P., Shi-Wen X., Knight C., and Black C.M. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br. J. Rheumatol. 37 1 (1998) 15-20
6. MacGregor A.J., Canavan R., Knight C., Denton C.P., Davar J., Coghlan J., and Black C.M. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 40 4 (2001) 453-459
7. Garcia de la Pena-Lefebvre P., Chanseaud Y., Tamby M.C., Reinbolt J., Batteux F., Allanore Y., Kahan A., Meyer O., Benveniste O., Boyer O., Guillevin L., Boissier M.C., and Mouthon L. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clin. Immunol. 111 3 (2004) 241-251
8. Masi A.T., Rodnan G.P., Medsger T.A., Altman R., D'Angelo W., Fries J., Leroy E.C., et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23 (1980) 581-590
9. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T.A., Rowell N., and Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15 2 (1988) 202-205
10. Steen V.D., Costantino J.P., Shapiro A.P., and Medsger T.A. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann. Intern. Med. 113 5 (1990) 352-357
11. Chanseaud Y., Pena-Lefebvre P.G., Guilpain P., Mahr A., Tamby M.C., Uzan M., Guillevin L., Boissier M.C., and Mouthon L. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin. Immunol. 109 2 (2003) 165-178
12. Tamby M.C., Chanseaud Y., Humbert M., Fermanian J., Guilpain P., Garcia-de-la-Pena-Lefebvre P., Brunet S., Servettaz A., Weill B., Simonneau G., Guillevin L., Boissier M.C., and Mouthon L. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60 9 (2005) 765-772
13. Messer M., Griffiths M., Rismiller P.D., and Shaw D.C. Lactose synthesis in a Monotreme, the Echidna (Tachyglossus aculeatus): isolation and amino acid sequence in Echidna a-lactalbumin. Comp. Biochem. Physiol. 118b (1997) 403-410
14. Kumar V., Kowalewski C., Koelle M., Qutaishat S., Chorzelski T.P., Beutner E.H., Jarzabek-Chorzelska M., Kolacinska Z., and Jablonska S. Scl-70 antigen stability and its effect on antibody detection in scleroderma. J. Rheumatol. 15 10 (1988) 1499-1502
15. Briolay J., Gioud M., Monier J.C., Rodde J.L., Cohen J., Roux B., and Kaliss B. Antinuclear antibodies detected by indirect immunofluorescence on HEp2 cells and by immunoblotting in patients with systemic sclerosis. Autoimmunity 2 2 (1989) 165-176
16. Alderuccio F., Barnett A.J., Campbell J.H., Pedersen J.S., and Toh B.H. Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis. Clin. Exp. Immunol. 64 1 (1986) 94-100
17. Steen V.D., Powell D.L., and Medsger T.A.J. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 31 (1988) 196-203